Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Active not recruiting × NSCLC × Clear all

Phase

Phase 2 7 Phase 1 1

Status

Recruiting 3 Withdrawn 2 Unknown 1 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 99 Neoplasms 70 Breast Neoplasms 69 Melanoma 66 Neoplasm Metastasis 53 Leukemia, Myeloid, Acute 53 Colorectal Neoplasms 50 Lymphoma, Non-Hodgkin 48 Lung Neoplasms 48 Glioblastoma 48 Ovarian Neoplasms 46 Recurrence 42 Pancreatic Neoplasms 42 Multiple Myeloma 42 Prostatic Neoplasms 41 Carcinoma, Renal Cell 41 Squamous Cell Carcinoma of Head and Neck 38 Leukemia, Lymphocytic, Chronic, B-Cell 31 Brain Neoplasms 30 Triple Negative Breast Neoplasms 29 Myelodysplastic Syndromes 27 Glioma 26 Stomach Neoplasms 25 Lymphoma, Large B-Cell, Diffuse 24 Lymphoma, B-Cell 24 Lymphoma 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Carcinoma, Hepatocellular 22 Leukemia 21 Lymphoma, Follicular 20

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04858958 2025-11-19

FAVOUR

Allist Pharmaceuticals, Inc.

Phase 1 Active not recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡